InnovAge Holding Corp. (INNV) Stock

InnovAge Holding Corp. (INNV) is a Healthcare stock trading at $10.92 (as of 2026-08-25), with a market capitalization of $1.48B. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

InnovAge Holding Corp. provides medical and related services for seniors through the Program of All-Inclusive Care for the Elderly (PACE) model. Its services include in-home and in-center care (such as primary and therapy services, dental and mental health care), along with transportation and care management for PACE participants in multiple U.S. states.

Understand InnovAge Holding Corp.: how it makes money

InnovAge operates PACE (Program of All-Inclusive Care for the Elderly) centers, bundling a senior's full medical, therapeutic, and personal-care needs under a single Medicare/Medicaid capitation payment. Revenue scales with the number of enrolled participants, so the core growth lever is adding seniors and geographic centers rather than winning new contracts.

Medicare and Medicaid pay a fixed monthly per-participant rate that covers every medical service the enrolled senior needs, so all profit or loss is decided by keeping per-person delivery costs below that capitation rate.

Business quality (Weak): The business is growing but unprofitable: a 24% gross margin and a negative 12% operating margin mean the capitation rate does not yet cover the full cost of delivering comprehensive elderly care. Business quality grade: Weak.

Bull case

  • Census growth drives predictable revenue: Quarterly revenue reached $300M, up 15% YoY, supported by 8,050 enrolled participants across 20 PACE centers. Under capitation, each new senior adds a fixed monthly revenue stream with no need to win competitive bids, making the path to scale straightforward.
  • Capitation locks in pricing: Capitation revenue of $250M represents roughly 83% of total quarterly revenue, meaning the bulk of the top line is contractually fixed by federal per-person rates. This insulates the revenue line from volume shocks and gives management time to work down costs before the P&L reflects it.

Bear case

  • Structurally unprofitable at the operating level: Operating margin is -12%, meaning the company loses roughly $36M per quarter before interest and taxes. Until per-participant delivery costs fall below the capitation rate, growth in census actually widens the absolute cash deficit.
  • Thin gross margin caps upside: Gross margin of 24% is very low for a healthcare services operator. Even a full 10-point operating-margin improvement would require driving labor and supplies costs down substantially, which is hard in a business delivering hands-on care to frail seniors across 20 locations.
Valuation — source: SEC EDGAR (first-party)
Price$10.92
Market Cap$1.48B
EV / EBITDA169.9
Price / Book6.37
Price / Sales1.56
FCF Yield2.9%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$853.70M
Net Margin-3.6%
Revenue Growth (YoY)15.5%
EPS Growth (YoY)175.0%
FCF Growth (YoY)-33.1%
Financial Health — source: SEC EDGAR
Altman Z-Score4.27 (safe)
Valuation vs Sector & Industry
Sector P/E (Healthcare)21.9
Industry P/E (Healthcare Services)25.4
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderT. Rowe Price Investment Management, Inc. ($49.19M)
Institutional Holders Tracked10
Company
SectorHealthcare
IndustryHealthcare Services
CEOPatrick Blair
Employees2,350
CountryUS
IPO Date2021-03-04

Related Companies (Healthcare Services; 8 comparable companies)

  • U.S. Physical Therapy, Inc. (USPH)
  • The Pennant Group, Inc. (PNTG)
  • LifeStance Health Group, Inc. (LFST)
  • P3 Health Partners Inc. (PIII)
  • GeneDx Holdings Corp. (WGS)
  • Privia Health Group, Inc. (PRVA)
  • Omada Health (OMDA)
  • Talkspace, Inc. (TALK)
INNV earnings history · INNV institutional & insider holders · INNV KPIs & operating metrics · INNV financials · INNV investor presentations & press releases · INNV SEC filings · INNV peers · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-08-25.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.